Want to join the conversation?
$VRX said that it has entered into a licensing agreement with Norgine B.V., the Netherlands-based pharma company to develop and commercialize the oral solution powder NER1006 in the U.S. and Canada. NER1006 is used for bowel preparation and its U.S. regulatory filing is anticipated in 2016.
Still in yesterday’s $PZZA shock. I thought everyone had more pizza this football season!!
$TSLA stock downgraded to sell from hold by brokerage firm CFRA Research. However, the firm lifted the price target by $35 to $240.
$LB shares have plummeted after a disappointing quarter.